APA (7th ed.) Citation

Fu, Q., Han, X., Zhu, C., Jiao, W., Liu, R., Feng, Z., . . . Huang, Y. (2024). Development of the first officially licensed live attenuated duck hepatitis A virus type 3 vaccine strain HB80 in China and its protective efficacy against DHAV-3 infection in ducks. Poultry science, 103(10), 104087. https://doi.org/10.1016/j.psj.2024.104087

Chicago Style (17th ed.) Citation

Fu, Qiuling, et al. "Development of the First Officially Licensed Live Attenuated Duck Hepatitis A Virus Type 3 Vaccine Strain HB80 in China and Its Protective Efficacy Against DHAV-3 Infection in Ducks." Poultry Science 103, no. 10 (2024): 104087. https://doi.org/10.1016/j.psj.2024.104087.

MLA (9th ed.) Citation

Fu, Qiuling, et al. "Development of the First Officially Licensed Live Attenuated Duck Hepatitis A Virus Type 3 Vaccine Strain HB80 in China and Its Protective Efficacy Against DHAV-3 Infection in Ducks." Poultry Science, vol. 103, no. 10, 2024, p. 104087, https://doi.org/10.1016/j.psj.2024.104087.